Lazard, Inc. (LAZ)
After hours:
| Previous Close | 39.63 |
| Open | 39.34 |
| Bid | 29.00 x 1000 |
| Ask | 0.00 x 1100 |
| Day's Range | 38.49 - 39.51 |
| 52 Week Range | 25.82 - 42.24 |
| Volume | |
| Avg. Volume | 1,138,037 |
| Market Cap | 3.436B |
| Beta (5Y Monthly) | 1.46 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.00 (5.09%) |
| Ex-Dividend Date | Feb 09, 2024 |
| 1y Target Est | N/A |
- Reuters
UPDATE 1-Lazard posts first-quarter profit on jump in assets
Lazard reported a first-quarter profit on Thursday, compared with a loss a year earlier, buoyed by a growth in assets at the boutique investment bank. Lazard's assets under management rose to $250 billion in the first quarter from $232 billion a year earlier. Revenue at Lazard's financial advisory segment, which advises on stock sales and mergers and acquisitions, rose 63% to $454 million in the quarter.
- Reuters
Lazard posts first-quarter profit on deals, assets boost
Lazard's profit was boosted by a string of high-profile mergers and acquisitions it advised on in the first quarter, such as ImmunoGen's $10.1 billion acquisition by AbbVie and CymaBay Therapeutic's $4.3 billion acquisition by Gilead. Revenue at Lazard's financial advisory segment, which advises on stock sales and mergers and acquisitions, rose 63% to $454 million in the quarter.
- Reuters
Lazard's first-quarter profit rises on jump in assets
Lazard reported a higher first-quarter profit on Thursday buoyed by a growth in assets at the boutique investment bank. Profit attributable to Lazard was $36 million, or 35 cents per share, in the quarter, compared with a loss of $22 million, or 27 cents per share, a year earlier.
